Compare HESM & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HESM | HAE |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | 3023 |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.9B |
| IPO Year | N/A | 1991 |
| Metric | HESM | HAE |
|---|---|---|
| Price | $33.20 | $83.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $42.25 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 1.3M | 671.6K |
| Earning Date | 01-28-2026 | 02-05-2026 |
| Dividend Yield | ★ 9.05% | N/A |
| EPS Growth | 18.64 | ★ 42.54 |
| EPS | 2.81 | ★ 3.44 |
| Revenue | ★ $1,613,000,000.00 | $1,327,850,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | ★ $11.89 | $24.09 |
| Revenue Growth | ★ 10.78 | N/A |
| 52 Week Low | $31.63 | $47.32 |
| 52 Week High | $44.14 | $87.32 |
| Indicator | HESM | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 66.64 |
| Support Level | $34.20 | $79.06 |
| Resistance Level | $34.82 | $81.27 |
| Average True Range (ATR) | 0.49 | 1.55 |
| MACD | -0.14 | -0.38 |
| Stochastic Oscillator | 2.42 | 88.74 |
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.